Recursion Pharmaceuticals
RXRX
#4494
Rank
S$2.41 B
Marketcap
$8.44
Share price
-9.11%
Change (1 day)
-3.16%
Change (1 year)

Recursion Pharmaceuticals (RXRX) - Cash on Hand

Cash on Hand as of September 2024 : S$0.57 Billion

According to Recursion Pharmaceuticals's latest financial reports the company has S$0.57 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Recursion Pharmaceuticals - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$0.51 B-29.85%
2022-12-31S$0.73 B5.57%
2021-12-31S$0.69 B101.38%
2020-12-31S$0.34 B268.07%
2019-12-31S$94.21 M